Investing.com -- An Alaska liquefied natural gas project developer reportedly received financing from Russian energy company ...

The once-daily drug, JNJ-6143, produced substantial reductions in prostate-specific antigen (PSA) levels, a blood marker commonly used to monitor prostate cancer progression and t ...

Lula’s choice to finally adopt a foundational artefact of modern life may be a tacit acknowledgment that he has failed to ...

Swiss equities are outperforming their European peers in October as investors shift towards defensive companies amid growing ...

Alan D. Schnitzer, Chairman and Chief Executive Officer of The Travelers Companies, Inc. (NASDAQ:TRV), sold 88,900 shares of ...

Five takeaways from Trump’s midterm campaign rallies ...

Murphy, Vice Chair and Chief Lending Officer at Wintrust Financial Corp (NASDAQ:WTFC), sold 7,136 shares of the company’s ...

Compass Therapeutics, Inc. (NASDAQ:CMPX) announced the publication of results from its Phase 2/3 COMPANION-002 study ...

Zymeworks Inc. (NASDAQ:ZYME) presented clinical data from a Phase 1 study of ZW191, an antibody-drug conjugate targeting ...

Another £60 million will support investments in British companies developing AI applications for robotics, autonomous systems ...

Boeing ’s dispute with a small Florida-based supplier has halted production of its 777 freighter for nearly two months and ...

Investing.com -- British Chancellor John Healey is expected to announce £20.4 billion ($27.3 billion) in additional funding ...